Which industries does Recombination Therapeutics operate in?
Recombination Therapeutics operates in Biotechnology, Pharmaceuticals, Health and Beauty, with operations based in United States.
Recombination Therapeutics Ingredient Intelligence
826 S 2nd St, Philadelphia, Pennsylvania, United States Biotechnology, Pharmaceuticals, Health and Beauty Manufacturer / Service Provider
Recombination Therapeutics operates in ingredient sourcing, based in United States.
0
Ingredients
0
Products
0
Certificates
0
People Records
Recombination Therapeutics Ingredient Footprint
Ingredient records lead this profile, with product and market context rendered when available.
Ingredient Market Signals
Ingredient Data Questions
Data-backed questions about Recombination Therapeutics in Biotechnology, Pharmaceuticals, Health and Beauty, United States.
When did Recombination Therapeutics start its operations?
Recombination Therapeutics was founded in 2018, making it 8 years active, headquartered in United States.
Where is Recombination Therapeutics headquartered?
Recombination Therapeutics is headquartered at 826 S 2nd St, Philadelphia, Pennsylvania, United States, United States.
Comparable Ingredient Companies
Recombination Therapeutics is related to companies such as SuperGen, Block Clinical Inc., Akston Biosciences Corporation, identified through shared industry signals, ingredient overlap, and product ecosystem alignment.
SuperGen
supergen.com
Block Clinical Inc.
blockclinical.com
Akston Biosciences Corporation
akstonbio.com
Evidence Life Science
nextlevells.com
